Prevalence of pulmonary tuberculosis in end stage renal disease patients: A single center study
DOI:
https://doi.org/10.61581/mjsp.v6i04.368Keywords:
prevalence, End stage renal disease, pulmonary tuberculosis, DialysisAbstract
Objective: To determine the prevalence of pulmonary tuberculosis and its associated factors among patients with end-stage renal disease at a single tertiary care center.
Methodology: This cross-sectional study included 145 patients diagnosed with ESRD. Demographic data, clinical characteristics, comorbid conditions, and dialysis duration were recorded. Pulmonary tuberculosis was diagnosed based on clinical, radiological, and microbiological criteria. Data were analyzed using appropriate statistical tests, and a p-value ?0.05 was considered statistically significant.
Results: The mean age of participants was 52.6 ± 13.4 years, with a male predominance (63.4%). The mean body mass index was 23.4 ± 3.2 kg/m². Hypertension was the most common comorbidity (74.5%), followed by diabetes mellitus (46.2%), ischemic heart disease (20%), and hepatitis C infection (15.2%). The overall prevalence of pulmonary tuberculosis among ESRD patients was 12.4%. PTB prevalence was significantly higher in patients undergoing dialysis for more than three years compared to those with a dialysis duration of three years or less (18.8% vs. 8.3%, p = 0.04).
Conclusion: ESRD patients on maintenance dialysis are at substantially increased risk of PTB. In our cohort, the prevalence of 12.4% and the significant association with longer dialysis duration underscore the need for sustained screening and preventive strategies.
Downloads
References
1. Rui-Lin RE, Wu-Xing ZH, HUANG W. Clinical analysis of pulmonary tuberculosis and extrapulmonary tuberculosis complicated in maintenance hemodialysis patients with end-stage renal disease. Jie Fang Jun Yi Xue Za Zhi. 2021;46(3):274.
2. Miao-Qin WA, Rui-Lin RE, Wu-Xing ZH, Zhou W, Wang Y, Huang W. Clinical characteristics and prognosis analysis of patients with end-stage renal disease in maintenance hemodialysis and complicated with pathogen-positive and-negative pulmonary tuberculosis. Jie Fang Jun Yi Xue Za Zhi. 2022;47(4):375.
3. Dlamini ST, Htet KM, Theint EC, Li WM, Chang HW, Tu HP. Assessment of the association of vitamin D and the risk of tuberculosis among end-stage kidney disease population. Life. 2022;12(11):1881.
4. Dodani SK, Babar ZU, Mohammad KG, Ali S, Mushtaq M, Batool S, et al. Clinical presentation and outcome of tuberculosis in chronic kidney disease stage 4 & 5 from a high TB burden country. PloS one. 2025;20(4):e0320907.
5. Wang PH, Lin SY, Liou HH, Chen CC, Shu CC, Lee CY, et al. Protective effect of BCG and neutrophil-to-lymphocyte ratio on latent tuberculosis in end stage renal disease. Infectious Diseases and Therapy. 2023;12(7):1907-20.
6. Chiu TF, Yu TM, Chiu CW, Lee BK, Lan TH, Li CY, et al. Increased risk of pulmonary and extrapulmonary tuberculosis infection in patients with polycystic kidney disease: a nationwide population-based study with propensity score-matching analysis. J Translat Med. 2021;19(1):253.
7. Puri S, Meshram HS, Batheja V, Modasiya B. WCN25-861 Prevalence and clinical spectrum of Tuberculosis in End stage kidney disease patients on hemodialysis. Kidney International Reports. 2025;10(2):S257.
8. Tantan R, SenLin Z, Peize Z, Quanzhen T, Zhengfu X, Lingwei W et al. Analysis on characteristics of tuberculosis in patients with chronic kidney disease. Electronic Journal of Emerg Infect Dis. 2023;8(1):52.
9. Mahendran S, Chowdhury P, Breen R, d’Ancona G, Milburn HJ. Improved awareness of tuberculosis infection in advanced stage chronic renal disease could reduce cases of active TB: lessons from four challenging cases. OBM Transplantation. 2021 Mar;5(1):1-4.
10. Alemu A, Diriba G, Seid G, Wondimu A, Moga S, Tadesse G, et al. Active tuberculosis among patients with presumptive tuberculosis with chronic kidney disease in a high tuberculosis burden country, Ethiopia: a multi-center study. IJID regions. 2025;14:100551.
11. Karur AK, Kumar P, Nayak-Rao S. Lessons for the clinical nephrologist: a rare presentation of extrapulmonary tuberculosis in a hemodialysis patient. Journal of Nephrology. 2025 Apr;38(3):1109-14.
12. Hsu KT, Lam KK, Liao SC, Liu CC, Chen JB. Prevalence of pulmonary tuberculosis in end-stage renal disease (ESRD) patients is not unusually high. Clin Nephrol. 1996 Apr;45(4):279-80.
13. Tanwani MR, Junejo A, Unar MA, Ejaz A, Kumar J. Frequency of tuberculosis in end stage renal disease (ESRD) patients: A cross sectional study. J Dow Univ Health Sci. J Dow Univ Health Sci 2025;19(2):105-111.
14. Beyene TM, Ayele RA, Hailemariam DM, Derso TZ, Gobezie GG. Burden of tuberculosis in end stage renal disease patients undergoing maintenance hemodialysis: A multicenter study and experience from Ethiopian dialysis setting. Int J Nephrol Renovasc Dis. 2024;17:59 69.
15. Min J, Kwon SK, Jeong HW, Han JH, Kim YJ, Kang M, et al. End stage renal disease and risk of active tuberculosis: A nationwide population based cohort study. J Korean Med Sci. 2018;33:e341.
16. Okada RC, Barry PM, Skarbinski J, Chitnis AS. Epidemiology, detection, and management of tuberculosis among end-stage renal disease patients. Infect Control Hosp Epidemiol. 2018;39(11):1367-1374.
17. Pavan M. The pattern of presentation and incidence of tuberculosis in patients on chronic hemodialysis. Sch J App Med Sci. 2020;8(9):2127 2131.
18. Chitnis AS, Trivedi M, Baijal R. Increased risk of tuberculosis among patients with end-stage renal disease: a systematic review and meta-analysis. Clin Infect Dis. 2017;65(4):684–692.
19. Ndamase P, Cohen K, Wilkinson RJ. Incidence and risk factors for tuberculosis among patients receiving dialysis at a tertiary hospital in South Africa. BMC Infect Dis. 2020;20:526.
20. Lee SS, Chou KJ, Su IJ, Chen YS, Fang HC, Huang TS, Tsai HC, Wann SR, Lin HH, Liu YC. High prevalence of latent tuberculosis infection in patients in end-stage renal disease on hemodialysis: Comparison of QuantiFERON-TB GOLD, ELISPOT, and tuberculin skin test. Infection. 2009 Apr;37(2):96-102.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Abdul Aziz, Zubair Ahmed, Rashid Asgher, Aimon Riaz, Nayyar Saleem, Khuram Bashir
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution (CC-BY) 4.0 License that allows others to share the work with an acknowledgment of the work’s authorship and initial publication in this journal.
